Diagnostic Challenge and Clinical Management of Juvenile Mandibular Chronic Osteomyelitis.
Caroline ZimmermannRúbia Teodoro StueppInês Beatriz da Silva RathLiliane Janete GrandoFilipe Ivan DanielMaria Inês MeurerPublished in: Head and neck pathology (2019)
Juvenile mandibular chronic osteomyelitis (JMCO) is a rare, idiopathic disease of chronic bone inflammation without suppuration, sinus tract formation, or sequestration. As the name suggests, this condition predominately affects children. The few cases of JMCO reported in the literature describe different treatments, and thus a standard therapy protocol has not yet been established. The aim of this paper is to report a clinical case in a 9-year-old girl that was misdiagnosed and unsuccessfully treated for 1 year. After experiencing persistent symptoms, a correct diagnosis was subsequently rendered based on the physical and radiographic examination as well as successful treatment with non-steroidal anti-inflammatory drugs (NSAIDs). The patient received drug therapy followed by periods of remission over a 4 year follow-up period. Diagnosis and treatment of JMCO is a challenge given the rarity and nonspecific signs and symptoms of this condition. Treatment with NSAIDs and regular follow-up is a conservative option for these patients.
Keyphrases
- anti inflammatory drugs
- newly diagnosed
- systematic review
- ejection fraction
- oxidative stress
- randomized controlled trial
- prognostic factors
- physical activity
- mental health
- stem cells
- emergency department
- sleep quality
- case report
- disease activity
- patient reported outcomes
- cell therapy
- replacement therapy
- systemic lupus erythematosus
- smoking cessation
- cone beam computed tomography
- postmenopausal women